Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）
NCT02189603
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
601
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis E
Interventions
BIOLOGICAL:
Recombinant (E. Coli) Hepatitis E Vaccine
Sponsor
Jun Zhang
Collaborators
[object Object]
[object Object]